Submitted by Anonymous (not verified) on 28 May 2026 - 16:30
Human medicines European public assessment report (EPAR): Pomalidomide Teva, pomalidomide, Date of authorisation: 14/11/2024, Revision: 2, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Pomalidomide Teva, pomalidomide, Date of authorisation: 14/11/2024, Revision: 2, Status: Authorised